Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2

BACKGROUND: The Adaptive COVID Treatment Trial-2 (ACTT-2) found that baricitinib in combination with remdesivir therapy (BCT) sped recovery in hospitalized coronavirus disease 2019 (COVID-19) patients vs remdesivir monotherapy (RMT). We examined how BCT affected progression throughout hospitalizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fintzi, Jonathan, Bonnett, Tyler, Tebas, Pablo, Marconi, Vincent C, Levine, Corri B, El Sahly, Hana M, McLellan, Susan L F, Benson, Constance A, Rostad, Christina A, Ganesan, Anuradha, Huprikar, Nikhil, Frank, Maria G, Mularski, Richard A, Atmar, Robert L, Park, Pauline K, Short, William R, Beigel, John H, Mehta, Aneesh K, Sweeney, Daniel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129131/
https://www.ncbi.nlm.nih.gov/pubmed/35818363
http://dx.doi.org/10.1093/ofid/ofac219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129131/
https://www.ncbi.nlm.nih.gov/pubmed/35818363
http://dx.doi.org/10.1093/ofid/ofac219

Ejemplares similares